Label Revisions Ordered for 15 Insulins, Erleada, Faslodex

May 20, 2020
The Ministry of Health, Labor and Welfare (MHLW) on May 19 ordered label revisions for 15 types of insulins including Eli Lilly’s Humalog/Lyumjev (insulin lispro) and two cancer drugs - Janssen Pharmaceutical’s Erleada (apalutamide) and AstraZeneca’s Faslodex (fulvestrant). The 15...read more